Micro Chemicals

Fundviser Capital (India) Ltd.

FUNDVISER

₹180.0

6.98% (11.75)

Market Cap

₹99 Cr.

P/E

230.63

Fundviser Capital (India) Ltd.
Overview
Financials
Benchmarking
Shareholding

Fundviser Capital (India) Ltd.

Fundviser Capital (India) Ltd.
Overview
Financials
Benchmarking
Shareholding

Price
Growth Table
Balance Sheet
Profit & Loss
Cash Flow
Cash Flow Analysis
Ratios
Quarterly Results
Reverse DCF

FAQs on Fundviser Capital (India) Ltd. Shareprice

Has the share price of Bagadia Colorchem grown faster than its competition?

Bagadia Colorchem has given better returns compared to its competitors.
Bagadia Colorchem has grown at ~111.35% over the last 5yrs while peers have grown at a median rate of 24.0%

Is Bagadia Colorchem stock expensive?

Bagadia Colorchem is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA.
Latest PE of Bagadia Colorchem is 230, while 3 year average PE is 64.69.
Also latest EV/EBITDA of Bagadia Colorchem is 40.77 while 3yr average is 288.

View FAQ's On Business

Growth Table

Fundviser Capital (India) Ltd.
Ishan Dyes and Chem.
Loading...
Genpharmasec
Loading...

In %	1yr	2yr	3yr	4yr	5yr	6yr	7yr	8yr	9yr	10yr
Share Price CAGR	29.78	327	129	96.31	112	62.68	45.84	48.17	46.70	35.69
TTM EPS CAGR	-19.85	—	—	72.44	67.22	25.78	—	26.07	-16.95	—
Sales CAGR	4,529	2,749	505	243	161	126	133	—	131	24.86
PAT Margin (Abs Growth)	50.71	67.78	-172	38.54	17.72	55.03	45.94	-7,504	58.32	67.11
PE CAGR	61.92	—	—	13.84	26.92	29.34	—	17.53	76.63	—
CFO CAGR	1,226	—	7.54	42.84	—	30.73	48.89	31.42	—	—

* Share price and PE growth are updated everyday. All other fields are as of latest financial year end. EPS adjusted for bonus and splits.

Balance Sheet

Fundviser Capital (India) Ltd.
Ishan Dyes and Chem.
Loading...
Genpharmasec
Loading...

In Rs. Cr.	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Assets	6.01	5.88	6.03	5.68	5.91	6.40	6.21	6.54	13.36	16.81
Non Current Assets	0.59	0.86	0.81	1.45	1.54	0.29	3.22	3.26	2.65	11.63
Net Block	0.09	0.08	0.08	0.00	0.00	0.00	—	0.00	0.00	0.05
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Intangible Assets Under Development	—	—	—	—	—	—	—	—	—	—
Long Term Investments	0.52	0.69	0.65	1.33	1.46	0.17	3.09	3.20	2.61	11.53
Current Assets	5.40	5.11	5.30	4.35	4.45	6.18	3.02	3.25	10.71	5.18
Inventory	—	—	—	—	—	—	—	—	—	—
Accounts Receivable	—	—	—	—	—	—	—	—	0.17	0.47
Short Term Investments	—	—	—	—	—	—	—	—	—	—
Cash & Bank Balances	5.13	4.73	4.92	4.20	4.24	4.15	2.96	3.18	7.94	1.87
Liabilities	6.01	5.88	6.03	5.68	5.91	6.40	6.21	6.54	13.36	16.81
Shareholders Funds	5.47	5.73	5.69	5.77	5.79	6.31	6.21	6.48	13.22	15.48
Share Capital	3.69	3.69	3.69	3.69	3.69	3.69	3.69	3.69	4.46	5.15
Reserves	1.78	2.04	2.00	2.08	2.10	2.62	2.52	2.79	6.79	10.32
Non Current Liabilities	0.03	-0.08	-0.07	-0.12	-0.08	-0.07	-0.02	0.02	0.00	—
Secured Loans	—	—	—	—	—	—	—	—	—	—
Unsecured Loans	—	—	—	—	—	—	—	—	—	—
Current Liabilities	0.52	0.23	0.40	0.03	0.20	0.16	0.02	0.04	0.13	0.22
Accounts Payable	0.00	0.03	0.03	0.01	0.05	0.04	0.02	0.04	0.03	0.04
Short Term Loans	0.40	0.19	0.36	—	—	—	—	—	—	—

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

Increase
Decrease
Total

No data available.

*Data is as of latest FY end

Profit & Loss

Fundviser Capital (India) Ltd.
Ishan Dyes and Chem.
Loading...
Genpharmasec
Loading...

In Rs. Cr.	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Sales	0.02	0.00	0.34	0.25	0.28	0.24	0.15	0.21	0.97	0.94
Operating Expenses	1.28	0.40	0.38	0.29	0.22	0.20	0.21	0.23	0.38	1.60
Raw Material	0.08	—	—	—	—	—	—	—	—	0.83
Chemicals	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Transportation Fuel	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Basic Chemicals	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Others	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Logistics	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Phthalic Anhydride	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Copper	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Material Cost (%)	416	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	87.69
Employee Cost	0.15	0.05	0.05	0.03	0.06	0.07	0.08	0.09	0.09	0.34
Power & Fuel Cost	—	0.00	0.00	0.00	—	—	—	—	—	—
Operating Profit	-1.26	-0.40	-0.04	-0.04	0.05	0.04	-0.06	-0.02	0.59	-0.66
Other Income	2.82	0.49	0.04	0.13	0.01	0.60	0.05	0.01	0.01	1.23
OPM (%)	-6,778	0.00	-11.27	-15.92	18.81	16.93	-37.84	-8.76	61.07	-69.75
Depreciation and Amortisation	0.13	0.00	0.00	0.01	—	—	—	—	—	0.01
Interest	0.02	0.06	0.02	0.01	0.00	—	—	—	0.01	0.00
Profit Before Tax	1.41	0.03	-0.03	0.07	0.06	0.64	-0.01	-0.01	0.59	0.56
Tax	-0.12	0.01	0.00	0.00	0.04	0.11	0.02	0.00	0.15	0.13
Net Profit	1.53	0.02	-0.03	0.07	0.02	0.52	-0.03	-0.01	0.44	0.43
Number of shares(Crs)	0.37	0.37	0.37	0.37	0.37	0.37	0.37	0.37	0.45	—
Dividend Payout Ratio(%)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—

TTM Values as of Mar 2025

Cash Flow

Fundviser Capital (India) Ltd.
Ishan Dyes and Chem.
Loading...
Genpharmasec
Loading...

In Rs. Cr.	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash from Operating Activity	-0.31	-0.17	-0.56	1.14	-0.67	-2.24	1.65	-0.21	-2.78	-0.28
Profit Before Tax	1.41	0.03	-0.03	0.07	0.06	0.64	-0.01	-0.01	0.59	0.56
Adjustments	-2.21	-0.37	-0.32	-0.34	-0.29	-0.83	-0.17	-0.22	-0.67	-0.25
OCF Before Working Capital	-0.80	-0.34	-0.34	-0.27	-0.22	-0.20	-0.18	-0.23	-0.08	0.31
Working Capital Changes	0.86	0.30	-0.18	1.43	-0.40	-2.01	1.93	0.02	-2.59	-0.51
Taxes Paid	-0.37	-0.13	-0.03	-0.03	-0.04	-0.03	-0.10	0.00	-0.11	-0.08
Cash from Investing Activity	4.03	0.41	0.38	-0.25	0.16	2.15	-2.83	0.43	1.17	-8.94
Net Fixed Assets Purchased	3.86	0.00	0.00	0.17	0.00	0.00	0.00	0.00	0.00	-0.04
Fixed Assets Purchased	—	—	—	—	—	—	—	—	—	-0.04
Fixed Assets Sold	3.86	—	—	0.17	—	—	—	—	—	—
Investment Purchased	-0.50	—	—	-1.17	-0.13	190	-3.00	—	—	-9.14
Investment Sold	—	—	—	0.46	—	1.90	—	0.29	0.93	—
Interest Recieved	0.27	0.41	0.38	0.29	0.29	0.25	0.16	0.11	0.22	0.24
Dividends Recieved	0.00	—	0.00	—	—	—	0.01	0.03	0.01	0.00
Subsidiary Investments	—	—	—	—	—	—	—	—	—	—
Cash from Financing Activity	0.37	-0.27	0.15	-0.37	-0.00	—	—	—	6.36	3.15
Proceeds From Shares	—	—	—	—	—	—	—	—	4.51	—
Net Long Term Borrowings	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Proceeds From Borrowings	—	—	—	—	—	—	—	—	—	—
Repayment From Borrowings	—	—	—	—	—	—	—	—	—	—
Interest Paid	-0.02	-0.06	-0.02	-0.01	-0.00	—	—	—	-0.01	-0.00
Dividend Paid	—	—	—	—	—	—	—	—	—	—
Net Cash Flow	4.09	-0.03	-0.03	0.52	-0.50	-0.09	-1.19	0.22	4.75	-6.07
Opening Cash & Cash Equivalents	0.18	0.13	0.10	0.07	0.59	4.24	4.15	2.96	3.18	7.93
Effect of FX	0.00	—	—	—	—	—	—	—	—	—
Closing Cash & Cash Equivalents	4.27	0.10	0.07	0.59	0.08	4.15	2.96	3.18	7.94	1.87
Net Capex (est)	-3.86	0.00	0.00	-0.17	0.00	0.00	0.00	0.00	0.00	0.04
Free Cash Flow (est)	3.55	-0.17	-0.56	1.30	-0.67	-2.24	1.65	-0.21	-2.78	-0.32

Cash Flow Analysis

Increase
Decrease
Total

No data available.

Ratios

= Dominant Factor

Fundviser Capital (India) Ltd.
Ishan Dyes and Chem.
Loading...
Genpharmasec
Loading...

	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Operational Ratios
Quick Ratio	46.08	10.38	21.87	13.11	156	21.72	37.57	176	91.39	80.07
Liquid Assets (Crs)	2.63	5.40	5.11	5.30	4.35	4.45	6.18	3.02	3.25	10.71
Current Liabilities (Crs)	0.06	0.52	0.23	0.40	0.03	0.20	0.16	0.02	0.04	0.13
Current Ratio	47.42	10.38	21.87	13.11	156	21.72	37.57	176	91.39	80.07
Current Assets (Crs)	2.71	5.40	5.11	5.30	4.35	4.45	6.18	3.02	3.25	10.71
Current Liabilities (Crs)	0.06	0.52	0.23	0.40	0.03	0.20	0.16	0.02	0.04	0.13
Interest Coverage Ratio	-22.80	77.90	1.52	-0.10	8.74	72.00	—	—	—	107
EBIT (Crs)	-0.62	1.43	0.09	-0.00	0.08	0.07	0.64	-0.01	-0.01	0.60
Interest Expenses (Crs)	0.03	0.02	0.06	0.02	0.01	0.00	0.00	0.00	0.00	0.01
Fixed Asset Turnover	0.47	0.13	0.00	2.50	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales (Crs)	3.62	0.02	0.00	0.34	0.25	0.28	0.24	0.15	0.21	0.97
Fixed Assets (Crs)	7.74	0.14	0.14	0.14	0.00	0.00	0.00	0.00	0.00	0.00
Cash Conversion Cycle	49.15	-2.16	-34.89	-85.62	-92.20	-131	0.00	0.00	0.00	64.67
Inventory Days	23.38	0.00	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Receivable	28.84	0.00	—	0.00	0.00	0.00	0.00	0.00	0.00	64.67
Days Payable	3.07	2.16	34.89	85.62	92.20	131	—	—	—	—
Debt to Equity Ratio	0.00	0.07	0.03	0.06	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt (Crs)	0.01	0.40	0.19	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Shareholders Equity (Crs)	3.94	5.47	5.73	5.69	5.77	5.79	6.31	6.21	6.48	13.22
Free Cash Flow/Sales (%)	14.16	19,051	0.00	-162	519	-241	-929	1,090	-99.14	-288
Free Cash Flow(est) (Crs)	0.51	3.55	-0.17	-0.56	1.30	-0.67	-2.24	1.65	-0.21	-2.78
Net Sales (Crs)	3.62	0.02	0.00	0.34	0.25	0.28	0.24	0.15	0.21	0.97
Profitability Ratios
Gross Margin (%)	28.97	-316	100.00	100.00	100.00	100.00	100.00	100.00	100.00	100.00
Op Profit Margin (%)	-4.77	-6,778	0.00	-11.27	-15.92	18.81	16.93	-37.84	-8.76	61.07
Operating Profit (Crs)	0.06	1.56	0.10	0.00	0.09	0.07	0.64	-0.01	-0.01	0.60
Net Sales (Crs)	3.62	0.02	0.00	0.34	0.25	0.28	0.24	0.15	0.21	0.97
Net Profit Margin (%)	-13.30	8,199	0.00	-9.09	28.22	7.40	218	-21.84	-4.77	45.94
Net Profit (Crs)	-0.48	1.53	0.02	-0.03	0.07	0.02	0.52	-0.03	-0.01	0.44
Net Sales (Crs)	3.62	0.02	0.00	0.34	0.25	0.28	0.24	0.15	0.21	0.97
ROCE (%)	-14.63	26.00	1.65	-0.04	1.44	1.14	10.23	-0.16	-0.12	4.52
EBIT (Crs)	-0.62	1.43	0.09	-0.00	0.08	0.07	0.64	-0.01	-0.01	0.60
Capital Employed (Crs)	4.22	5.49	5.64	5.63	5.65	5.70	6.24	6.19	6.50	13.23
Return on Assets (%)	-11.25	25.40	0.29	-0.52	1.25	0.35	8.18	-0.53	-0.15	3.32
Net Profit (Crs)	-0.48	1.53	0.02	-0.03	0.07	0.02	0.52	-0.03	-0.01	0.44
Total Assets (Crs)	4.27	6.01	5.88	6.03	5.68	5.91	6.40	6.21	6.54	13.36
ROIC (%)	-23.07	912	-95.84	-81.34	-37.22	160	1.74	-133	-19.40	16.48
Op Profit after Taxes (Crs)	-0.64	-1.51	-0.21	-0.05	-0.04	0.02	0.03	-0.19	-0.02	0.44
Invested Capital (Crs)	2.75	-0.17	0.22	0.06	0.12	0.01	1.92	0.14	0.12	2.68
ROE (%)	-12.21	27.94	0.29	-0.55	1.23	0.35	8.30	-0.53	-0.16	3.35
Net Profit Margin (%)	-13.30	8,199	0.00	-9.09	28.22	7.40	218	-21.84	-4.77	45.94
Asset Turnover ratio	0.85	0.00	0.00	0.06	0.04	0.05	0.04	0.02	0.03	0.07
Equity Multiplier	1.09	1.10	1.03	1.06	0.98	1.02	1.01	1.00	1.01	1.01
Adjusted EPS	-1.30	4.14	0.05	-0.08	0.19	0.06	1.42	-0.09	-0.03	0.99
Valuation Ratios
P/E	0.00	1.32	184	0.00	68.69	141	4.01	0.00	0.00	105
Price to Book	0.96	0.37	0.54	0.00	0.85	0.50	0.33	1.18	0.53	4.13
EV/EBITDA	38.22	-1.74	-15.08	-742	7.80	-20.84	-3.21	-432	-32.07	64.53
Dividend Yield (%)	0.00	0.00	0.00	—	0.00	0.00	0.00	0.00	0.00	0.00

Quarterly Results

Fundviser Capital (India) Ltd.
Ishan Dyes and Chem.
Loading...
Genpharmasec
Loading...

In Rs. Cr.	Mar'24	Jun'24	Sep'24	Dec'24	Mar'25
Net Sales	0.00	0.04	0.04	6.61	26.59
Operating Expenses	0.00	0.08	0.14	4.46	26.04
Increase/Decrease in Stock	0.00	0.00	0.00	0.00	0.00
Raw Material	0.00	0.01	0.00	4.14	20.08
Employee Cost	0.00	0.03	0.05	0.13	0.16
Selling and Distribution Expenses	0.00	0.00	0.00	0.00	0.00
Electricity, Power & Fuel Cost	0.00	0.00	0.00	0.00	0.00
Gen_AdminExpenses	0.00	0.01	0.01	0.01	-0.00
Miscellaneous Expenses	0.00	0.00	0.00	0.00	0.00
Operating Profit	0.00	-0.04	-0.09	2.15	0.55
Other Income	0.00	0.00	0.01	1.26	-0.86
Interest	0.00	0.00	0.00	0.00	0.12
PBDT	0.00	-0.04	-0.09	3.41	-0.42
Depreciation and Amortization	0.00	0.00	0.00	0.01	0.02
Profit Before Tax	0.00	-0.04	-0.09	3.40	-0.44
Tax	0.00	-0.01	-0.02	0.18	0.02
Profit After Tax	0.00	-0.03	-0.07	3.22	-0.46
Exceptional Items	0.00	0.00	0.00	0.00	0.00
Net Profit	0.00	-0.02	-0.03	1.92	-0.29
Quarterly Ratios
EPS	0.00	-0.04	-0.07	3.73	-0.56
Operating Profit Margin	0.00	-90.91	-216	32.55	2.08
Net Profit Margin	0.00	-72.73	-153	48.81	-1.74

Reverse DCF

Earnings

Discount Rate (%)

Terminal Multiple

5 YEAR

10 YEAR

20 YEAR

116.30%

Implied Growth Rate over a 5 year period*

43.00%

Implied Growth Rate over a 10 year period*

20.00%

Implied Growth Rate over a 20 year period*

*Implied Growth calculated using Newton-Raphson method.

Learn how to use Reverse DCF

FAQs on Fundviser Capital (India) Ltd. Financials

How strong is Bagadia Colorchem balance sheet?

Bagadia Colorchem balance sheet is weak and might have solvency issues

Is the debt of Bagadia Colorchem increasing or decreasing?

Yes, The net debt of Bagadia Colorchem is increasing.
Latest net debt of Bagadia Colorchem is ₹4.83 Crs as of Mar-25.
This is greater than Mar-24 when it was -₹15.83 Crs.

Is the profitablity of Bagadia Colorchem improving?

Yes, profit is increasing.
The profit of Bagadia Colorchem is ₹0.44 Crs for Mar 2024, -₹0.01 Crs for Mar 2023 and -₹0.03 Crs for Mar 2022

Does Bagadia Colorchem pay decent dividends?

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Bagadia Colorchem latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Bagadia Colorchem allocated its funds?

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments

View FAQ's On Shareholding

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Fundviser Capital (India) Ltd.

Fundviser Capital (India) Ltd.

Has the share price of Bagadia Colorchem grown faster than its competition?

Is Bagadia Colorchem stock expensive?

How strong is Bagadia Colorchem balance sheet?

Is the debt of Bagadia Colorchem increasing or decreasing?

Is the profitablity of Bagadia Colorchem improving?

Does Bagadia Colorchem pay decent dividends?

How has Bagadia Colorchem allocated its funds?

SIGN UP FOR FREE